Short bowel condition Completed Phase 3 Trials for Teduglutide (DB08900)

Also known as: Short-bowel syndrome / Short Bowel Syndrome / Congenital volvulus

IndicationStatusPhase
DBCOND0020575 (Short bowel condition)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03663582Study of Teduglutide in Japanese Participants With Short Bowel SyndromeTreatment
NCT02980666Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral SupportTreatment
NCT02682381Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral NutritionTreatment
NCT00081458Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel SyndromeTreatment
NCT00172185Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)Treatment
NCT00798967Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) SubjectsTreatment
NCT00930644Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)Treatment
NCT01560403A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021Treatment
NCT01952080A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel SyndromeTreatment
NCT02340819Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)Treatment